Press "esc" to clear
Go to Advanced Search

Showing results

3140 of 103681
  • Embargo expired:
    13-Aug-2018 6:30 PM EDT

Article ID: 698655

Switching Anti-Psychotic Medications Doesn’t Improve Outcomes in First-Episode Schizophrenia Patients

Mount Sinai Health System

Switching anti-psychotic medications does not improve clinical outcomes in patients with first-episode schizophrenia who haven’t responded to treatment, Mount Sinai researchers have shown for the first time.

Released:
7-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698925

One Antiplatelet Drug After Heart Valve Replacement Works as Well as Two, with Fewer Complications

Loyola University Health System

Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A Loyola Medicine study has found that a single antiplatelet drug may work just as well, with lower risks of life-threatening bleeding and other complications.

Released:
13-Aug-2018 6:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698923

انتخاب الدكتور جانريكو فاروجيا رئيس ومدير تنفيذي لمؤسسة Mayo Clinic

Mayo Clinic

انتخاب الدكتور جانريكو فاروجيا رئيس ومدير تنفيذي لمؤسسة Mayo Clinic

Released:
13-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698921

Muslim Community Activists from Across the U.S. Meet to Address Muslim Community Health Issues

University of Chicago Medical Center

As part of a project titled Engaging Muslim Activists for Research on Community Health (E-MARCH) -- led by Aasim Padela, MD, associate professor of medicine and Director of Initiative on Islam and Medicine at the University of Chicago -- UMMA Clinic of Los Angeles, California, hosted fourteen Muslim community leaders to discuss Muslim health disparities and community-based health research.

Released:
13-Aug-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698922

Gianrico Farrugia, M.D. 当选为Mayo Clinic的新总裁兼首席执行官

Mayo Clinic

Mayo Clinic董事会(Mayo Clinic Board of Trustees)于8月10日星期五宣布,原Mayo Clinic副总裁兼佛罗里达Mayo Clinic首席执行官Gianrico Farrugia, M.D. (JAN-ree-koh fa-ROO-jah) 将接替John Noseworthy, M.D. 担任Mayo Clinic总裁兼首席执行官。Dr. Noseworthy在 今年年底退休之前仍为Mayo Clinic的总裁兼首席执行官。Drs. Noseworthy and Farrugia将在这一过渡时期密切合作。

Released:
13-Aug-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698912

University Hospitals Seidman Cancer Center Opens Car-T Therapy Study for Non-Hodgkin’s Lymphoma

University Hospitals Cleveland Medical Center

University Hospitals Seidman Cancer Center in Cleveland has a new clinical trail to study the safety of CAR-T therapy for Non-Hodgkin's lymphoma. In addition, UH is manufacturing on-site the cells used in the trial.

Released:
13-Aug-2018 3:45 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    13-Aug-2018 3:00 PM EDT

Article ID: 698835

When it Comes to Regrowing Tails, Neural Stem Cells Are the Key

Health Sciences at the University of Pittsburgh

It’s a longstanding mystery why salamanders can perfectly regenerate their tails whereas lizard tails grow back all wrong. By transplanting neural stem cells between species, Pitt researchers have discovered that the lizard’s native stem cells are the primary factor hampering tail regeneration.

Released:
10-Aug-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698901

Racial and Ethnic Minority Patients Have Lower Rates of Medicare Preventive Care Visits – Income and Education Partially Explain the Difference

Wolters Kluwer Health: Lippincott Williams and Wilkins

Medicare patients nationwide have low rates of preventive care visits – with the lowest rates found in older adults of minority race/ethnicity, reports a study in the September issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released:
13-Aug-2018 2:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Steven_Qian.jpg

Article ID: 698906

NDSU Research Foundation and OncoThira Announce License Agreement to Develop & Market Compounds Discovered at NDSU for the Treatment of Cancer

North Dakota State University

OncoThira will develop and market compounds discovered by NDSU pharmaceutical sciences researcher Steven Qian that take advantage of high COX-2 expression in cancer to down regulate cancer promoting prostaglandins and elevate production of the recently characterized anti-cancer compound 8-HOA

Released:
13-Aug-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698908

Rethinking the Stroke Rule "Time is Brain"

Loyola University Health System

In 1993, neurologist Camilo Gomez, MD, coined a phrase that became a fundamental rule of stroke care: "Time is brain!" The longer therapy is delayed, the less chance it will succeed. But the "time is brain" rule is not as simple as it once seemed, Dr. Gomez now reports in the Journal of Stroke & Cerebrovascular Diseases.

Released:
13-Aug-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

3140 of 103681





Chat now!